◆英語タイトル:Rna Diagnostics Inc - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8013787
◆発行会社(調査会社):
GlobalData
◆発行日:2017年10月27日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that develops medical diagnostics molecular diagnostic technologies. The company provides solutions to manage cancer and other disease states. It offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. Rna Diagnostics’ RNA disruption assay allows oncologists to examine the biological structure of a patient’s tumor during treatment to determine its response to chemotherapy. The company collaborates with university researchers, research clinicians and hospitals in Canada, the US and other countries. The company operates through laboratories in Ontario. Rna Diagnostics is headquartered in Toronto, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Rna Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Rna Diagnostics Inc Company Overview 4
Rna Diagnostics Inc Company Snapshot 4
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Rna Diagnostics Inc – Pipeline Analysis Overview 7
Rna Diagnostics Inc – Key Facts 7
Rna Diagnostics Inc – Major Products and Services 8
Rna Diagnostics Inc Pipeline Products by Development Stage 9
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Rna Diagnostics Inc Pipeline Products Overview 13
RNA Disruption Assay – Breast Cancer 13
RNA Disruption Assay – Breast Cancer Product Overview 13
RNA Disruption Assay – Breast Cancer Clinical Trial 14
RNA Disruption Assay – Head & Neck Cancer 15
RNA Disruption Assay – Head & Neck Cancer Product Overview 15
RNA Disruption Assay – Ovarian Cancer 16
RNA Disruption Assay – Ovarian Cancer Product Overview 16
RNA Disruption Assay – Rectal Cancer 17
RNA Disruption Assay – Rectal Cancer Product Overview 17
RNA Disruption Assay – Sarcoma 18
RNA Disruption Assay – Sarcoma Product Overview 18
Rna Diagnostics Inc – Key Competitors 19
Rna Diagnostics Inc – Key Employees 20
Rna Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Rna Diagnostics Inc, Recent Developments 22
Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board 22
Jun 14, 2017: Rna Diagnostics Launches BREVITY – International Validation Trial of RDA in Breast Cancer 22
Sep 15, 2016: Further Evidence RDA May Predict Clinical Outcome Of Chemotherapy In Journal Of The National Cancer Institute 23
Apr 01, 2016: Rna Diagnostics appoints Dr. Jeremy Bridge-Cook President and CEO 23
Feb 18, 2016: Paul Lucas joins the Board of Directors at Rna Diagnostics 24
May 30, 2013: Rna Diagnostics Selected To Participate In Excite Program To Evaluate RNA Disruption Assay 24
Feb 19, 2013: Rna Diagnostics Gets $462,500 Grant From FedDev Ontario For RNA Disruption Assay 25
Nov 02, 2012: Denis Ho joins Rna Diagnostics’ Board of Directors 25
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 30
List of Tables
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Rna Diagnostics Inc Pipeline Products by Equipment Type 5
Rna Diagnostics Inc Pipeline Products by Indication 6
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 6
Rna Diagnostics Inc, Key Facts 7
Rna Diagnostics Inc, Major Products and Services 8
Rna Diagnostics Inc Number of Pipeline Products by Development Stage 9
Rna Diagnostics Inc Pipeline Products Summary by Development Stage 10
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status 11
Rna Diagnostics Inc Ongoing Clinical Trials Summary 12
RNA Disruption Assay - Breast Cancer - Product Status 13
RNA Disruption Assay - Breast Cancer - Product Description 13
RNA Disruption Assay - Breast Cancer - Breast Cancer Response Evaluation for Individualized Therapy: BREVITY 14
RNA Disruption Assay - Head & Neck Cancer - Product Status 15
RNA Disruption Assay - Head & Neck Cancer - Product Description 15
RNA Disruption Assay - Ovarian Cancer - Product Status 16
RNA Disruption Assay - Ovarian Cancer - Product Description 16
RNA Disruption Assay - Rectal Cancer - Product Status 17
RNA Disruption Assay - Rectal Cancer - Product Description 17
RNA Disruption Assay - Sarcoma - Product Status 18
RNA Disruption Assay - Sarcoma - Product Description 18
Rna Diagnostics Inc, Key Employees 20
Rna Diagnostics Inc, Other Locations 21
Glossary 28